Sepsis is a life-threatening organ dysfunction caused by the host's dysfunctional response to infection. Sepsis-induced cardiomyopathy (SICM), as a serious complication of sepsis, is an acute reversible cardiac dysfunction syndrome unrelated to myocardial ischemia, which affects the outcome and prognosis of sepsis. As a complex microbial system, gut microbiota has been confirmed to be involved in the development of coronary heart disease, hypertension, heart failure and other cardiovascular diseases, and is also related to the occurrence and development of sepsis. However, there are few studies on the relationship between gut microbiota and SICM. This paper reviews the current research progress on gut microbiota and SICM, aiming at provide a new idea for clinical treatment of SICM.
Keyphrases
- septic shock
- acute kidney injury
- heart failure
- intensive care unit
- left ventricular
- cardiovascular disease
- drug induced
- blood pressure
- diabetic rats
- risk assessment
- type diabetes
- randomized controlled trial
- microbial community
- atrial fibrillation
- coronary artery disease
- mechanical ventilation
- smoking cessation
- cardiac resynchronization therapy